| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 104.984.970 $ | +19.153.953 $ | +50,5 % | 15 | 84.452.656 $ | +84.452.656 $ | 10 | |||||
| Morse Asset Management, Inc | → 0 | 13.771.294 $ | -12.792.290 $ | -48,2 % | 1 | 26.563.584 $ | +26.563.584 $ | 1 | |||
| X4 Pharmaceuticals, Inc | XFOR | → 0 | Neutral | 15.375.329 $ | +483.969 $ | +3,2 % | 1 | 14.891.360 $ | +14.891.360 $ | 1 | |
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 11.220.235 $ | +9.333.994 $ | +494,8 % | 1 | ||||
| Relay Therapeutics, Inc. | RLAY | → 0 | Schwach | 8.969.497 $ | +1.343.171 $ | +17,6 % | 1 | 7.626.326 $ | +7.626.326 $ | 1 | |
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 7.900.616 $ | -206.926 $ | -2,6 % | 1 | 8.107.542 $ | +8.107.542 $ | 1 | |
| Veradermics, Inc | MANE | → 0 | Neutral | 6.496.809 $ | +6.496.809 $ | 1 | |||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 5.813.602 $ | +2.221.140 $ | +61,8 % | 1 | 3.592.462 $ | +3.592.462 $ | 1 | |
| COMPASS Pathways plc | CMPS | → 0 | Neutral | 4.532.897 $ | -1.122.978 $ | -19,9 % | 1 | 5.655.875 $ | +5.655.875 $ | 1 | |
| Pharvaris N.V. | PHVS | → 0 | Neutral | 5.615.309 $ | +99.386 $ | +1,8 % | 1 | 5.515.923 $ | +5.515.923 $ | 1 | |
| Septerna, Inc. | SEPN | → 0 | Neutral | 4.674.892 $ | -748.995 $ | -13,8 % | 1 | 5.423.887 $ | +5.423.887 $ | 1 | |
| Aclaris Therapeutics, Inc. | ACRS | → 0 | Neutral | 5.015.835 $ | +5.015.835 $ | 1 | |||||
| Inhibikase Therapeutics, Inc. | IKT | → 0 | Neutral | 4.489.981 $ | +902.481 $ | +25,2 % | 1 | 3.587.500 $ | +3.587.500 $ | 1 | |
| LeonaBio, Inc. | LONA | → 0 | Neutral | 4.047.246 $ | +1.066.929 $ | +35,8 % | 1 | ||||
| Damora Therapeutics, Inc. | GLTO | → 0 | 3.600.100 $ | +3.600.100 $ | 1 | ||||||
| Allogene Therapeutics, Inc. | ALLO | → 0 | Schwach | 3.488.197 $ | +3.488.197 $ | 1 | |||||
| uniQure N.V. | QURE | → 0 | Schwach | 3.461.328 $ | +3.461.328 $ | 1 | |||||
| 104.984.970 $ | +19.153.953 $ | +50,5 % | 15 | 84.452.656 $ | +84.452.656 $ | 10 | |||||